Journal
Spotlights
Webinars
Channels
Analytics
Manufacturing
Vectors
Regulatory
Supply Chain
Translational Research & Clinical Development
Business and Finance
Reports
Regulatory Insights
Clinical Trends
Innovation Insights
Business Insights
Investor Insights
FastFacts
Media Kit
Media Kit
Editorial calendar
Sponsorship opportunities
Webinars
About
Submit your manuscript
Meet the team
Get in touch
Immuno-Oncology Insights
Login
Register
Update your profile
Logout
Cell & Gene Therapy
INSIGHTS
Business Insights January 2021
February 2021
Download full report
Business Insight: cell & gene therapy
J Mulryne,
D San Martin,
J Schmidt
et al.
1 February 2021
Expert Insight
Read more
Previous reports
Business Insights February 2022
FEATURING
COMMENTARY:
Regenerative medicine: new paradigms
J Lambert
COMMENTARY:
Advancing patient access to cell & gene therapies: partnerships, pilots, & psyche
H McDonald
INTERVIEW:
Building from the ground up: business culture learnings for cell and gene therapy biotechs
J Noble
Read more
Business Insights October 2021
FEATURING
INTERVIEW:
Establishing gene therapies as a relevant, recognized and accessible therapeutic category
T Salimullah
INTERVIEW:
Analyzing trends and opportunities in the advanced therapy tool and service provider sectors
D Anderson
Read more
Business Insights July 2021
FEATURING
EXPERT INSIGHT:
Solving the problem of financing one-time treatments with evidence uncertainty: which types of outcomes-based payment models could work best for novel CAR-T therapies in multiple myeloma? A systematic review of the published literature
C Dietrich,
C Hague,
S Boes
COMMENTARY:
Critical need for establishing value that justifies the current rising costs of cell and gene therapy
R Maziarz
Read more
Previous
Next
Other reports from Cell and Gene Therapy insights
Read more
Read more
Read more
Read more
×
Please enter your email to register
Register